Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Corcept Therapeutics (CORT)

Corcept Therapeutics (CORT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,670,608
  • Shares Outstanding, K 117,312
  • Annual Sales, $ 353,870 K
  • Annual Income, $ 106,010 K
  • 60-Month Beta 0.77
  • Price/Sales 7.60
  • Price/Cash Flow 24.33
  • Price/Book 5.09
Trade CORT with:

Options Overview

Details
  • Implied Volatility 96.23%
  • Historical Volatility 35.61%
  • IV Percentile 89%
  • IV Rank 33.73%
  • IV High 208.16% on 11/12/20
  • IV Low 39.26% on 03/12/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 43
  • Volume Avg (30-Day) 231
  • Put/Call OI Ratio 0.97
  • Today's Open Interest 13,144
  • Open Int (30-Day) 3,522

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 0.21
  • Number of Estimates 2
  • High Estimate 0.23
  • Low Estimate 0.19
  • Prior Year 0.25
  • Growth Rate Est. (year over year) -16.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
22.12 +2.92%
on 04/13/21
26.16 -12.98%
on 03/22/21
-2.74 (-10.73%)
since 03/16/21
3-Month
22.12 +2.92%
on 04/13/21
31.18 -26.99%
on 02/09/21
-5.38 (-19.10%)
since 01/15/21
52-Week
11.91 +91.14%
on 05/01/20
31.18 -26.99%
on 02/09/21
+10.76 (+89.71%)
since 04/16/20

Most Recent Stories

More News
Why Is Corcept (CORT) Down 11.1% Since Last Earnings Report?

Corcept (CORT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CORT : 22.76 (-0.76%)
Corcept (CORT) Begins Adrenal Cancer Study on Relacorilant

Corcept (CORT) commences phase Ib study on relacorilant in combination with Keytruda for treating patients with adrenal cancer with cortisol excess.

PFE : 38.57 (+2.58%)
MRK : 77.47 (+1.06%)
BMY : 65.46 (+1.58%)
CORT : 22.76 (-0.76%)
Corcept Therapeutics Initiates Phase 1b Trial of Relacorilant Plus Pembrolizumab (Keytruda(R)) in Patients with Adrenal Cancer with Cortisol Excess

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating...

MRK : 77.47 (+1.06%)
CORT : 22.76 (-0.76%)
Oversold Conditions For Corcept Therapeutics (CORT)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

CORT : 22.76 (-0.76%)
Corcept Therapeutics Expands Executive Team; Atabak Mokari Joins As Chief Financial Officer; Charles Robb Named Chief Business Officer

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating...

CORT : 22.76 (-0.76%)
Corcept (CORT) Q4 Earnings In Line, Revenues Miss Estimates

Corcept's (CORT) earnings meet estimates in the fourth quarter of 2020 while revenues miss the same.

PFE : 38.57 (+2.58%)
BMY : 65.46 (+1.58%)
CORT : 22.76 (-0.76%)
Corcept: 4Q Earnings Snapshot

MENLO PARK, Calif. (AP) _ Corcept Therapeutics Inc. (CORT) on Tuesday reported fourth-quarter profit of $26 million.

CORT : 22.76 (-0.76%)
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2020 Audited Financial Results

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of drugs to treat severe metabolic, oncologic and psychiatric disorders by modulating...

CORT : 22.76 (-0.76%)
AMRX or CORT: Which Is the Better Value Stock Right Now?

AMRX vs. CORT: Which Stock Is the Better Value Option?

AMRX : 5.89 (-0.17%)
CORT : 22.76 (-0.76%)
Corcept (CORT) Posts Preliminary '20 Results, Gives 2021 View

Corcept (CORT) provides preliminary revenue figures for fourth-quarter and full-year 2020. The company also issues revenue guidance for 2021. Shares down in after-hours trading.

PFE : 38.57 (+2.58%)
MRK : 77.47 (+1.06%)
BMY : 65.46 (+1.58%)
CORT : 22.76 (-0.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

See More Share

Business Summary

Corcept Therapeutics Incorporated is a pharmaceutical company. It is engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. The company focuses on disorders that are associated with a steroid hormone called cortisol....

See More

Key Turning Points

3rd Resistance Point 23.88
2nd Resistance Point 23.52
1st Resistance Point 23.14
Last Price 22.76
1st Support Level 22.41
2nd Support Level 22.05
3rd Support Level 21.67

See More

52-Week High 31.18
Fibonacci 61.8% 23.82
Last Price 22.76
Fibonacci 50% 21.55
Fibonacci 38.2% 19.27
52-Week Low 11.91

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar